FDA Inspection 643147 — Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited — FEI 3005757050

The FDA completed an inspection of Glenmark Pharmaceuticals Limited on November 13, 2009 in Solan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 13, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Solan (India)